.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer last year for a whopping $43 b...
.On the heels of a stage 3 succeed that neglected to make an impression on clients, Ironwood Pharmac...
.Do not quit Monte Rosa Rehabs now. The Boston-based biotech is actually enjoying after authorizing ...
.Invite to this week's Chutes & Ladders, our summary of notable management hirings, shootings and...
.Commemorating his business's upsized initial public offering (IPO), Septerna chief executive office...
.AbbVie has returned to the resource of its antipsychotic goliath Vraylar in search of yet another b...
.GenSight Biologics is weeks far from running out of loan. Once more. The biotech simply possesses s...
.Monopar Rehabs is recuperating a medicine from the scrap heap of AstraZeneca's unusual disease pipe...
.Along with new data out on Arcus Biosciences' speculative HIF-2a prevention, one team of experts es...
.After developing a genetics treatment partnership along with Dyno Therapies in 2020, Roche is actua...